Holy Cross Hospital has reached a new, multi-year agreement with Humana that will keep Holy Cross facilities and physicians in Humana's provider network. This will guarantee Humana members in-network access to Holy Cross without any disruption of care.
The Michael and Dianne Bienes Comprehensive Cancer Center has been granted a three-year, full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.
The Holy Cross Hospital cancer research program announces that it has a clinical trial that provides BRCA testing at no charge for women and men with a certain type of breast cancer. The trial is called the Brocade 3 Study. For BRCA-positive patients the clinical trial involves an investigational medication given along with standard of care treatment.
FORT LAUDERDALE, Fla. -- (September 14, 2016) Phil Smith, president and CEO of the Phil Smith Automotive Group, has donated $7 million to fund state-of-the-art neurological care at Holy Cross Hospital. A longtime supporter of the hospital, Smith has designated these funds to name the Phil Smith Neuroscience Institute and to establish the Phil Smith ALS and Movement Disorder Clinic. He is earmarking $2 million of the gift as matching funds in a community challenge to bring first class research and treatments to South Florida.
Holy Cross Hospital has received $50,000 from Community Foundation of Broward for its “Cancel Cancer - Cancer Research & Support” program at the Holy Cross Cancer Research Institute. This will enable Holy Cross Hospital to transform the way cancer patients are treated based on their genetic makeup or the genetic profile of an individual’s tumor. The Cancel Cancer grant makes it possible to bring these new personalized medicine cancer therapies to 50-100 Broward patients who have not previously had access to genetic screening.